Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9226 |
High Similarity |
NPD2801 |
Approved |
0.8981 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8917 |
High Similarity |
NPD1934 |
Approved |
0.882 |
High Similarity |
NPD5494 |
Approved |
0.872 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.872 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.872 |
High Similarity |
NPD6166 |
Phase 2 |
0.871 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8645 |
High Similarity |
NPD1511 |
Approved |
0.8634 |
High Similarity |
NPD3882 |
Suspended |
0.8571 |
High Similarity |
NPD3817 |
Phase 2 |
0.8563 |
High Similarity |
NPD7054 |
Approved |
0.8553 |
High Similarity |
NPD4380 |
Phase 2 |
0.8535 |
High Similarity |
NPD1512 |
Approved |
0.8512 |
High Similarity |
NPD7074 |
Phase 3 |
0.8512 |
High Similarity |
NPD7472 |
Approved |
0.8503 |
High Similarity |
NPD3818 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8373 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8363 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8353 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8343 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8333 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8313 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8304 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8293 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8221 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8205 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8171 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8171 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7987 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7976 |
Intermediate Similarity |
NPD919 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7931 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7885 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7857 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7805 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7805 |
Intermediate Similarity |
NPD920 |
Approved |
0.7791 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7791 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7791 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7791 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7756 |
Intermediate Similarity |
NPD943 |
Approved |
0.775 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7702 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7614 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7595 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7594 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7542 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7532 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7528 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7484 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7455 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7453 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7439 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7418 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7405 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD37 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7356 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7341 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7341 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7337 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7326 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7326 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7308 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7254 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7253 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7249 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7232 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7229 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7198 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7193 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7189 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7584 |
Approved |
0.716 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD2403 |
Approved |
0.715 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.711 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7081 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7031 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7031 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7025 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7011 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7011 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6994 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD5353 |
Approved |
0.6981 |
Remote Similarity |
NPD2797 |
Approved |
0.6961 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6933 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6932 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD7240 |
Approved |
0.6901 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6899 |
Remote Similarity |
NPD9717 |
Approved |
0.6899 |
Remote Similarity |
NPD1608 |
Approved |
0.6894 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6893 |
Remote Similarity |
NPD4288 |
Approved |
0.689
|
Remote Similarity |
NPD4060 |
Phase 1 |